These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 8636004)
1. Induction of programmed death/apoptosis androgen-dependent mouse mammary tumor cell line (Shionogi Carcinoma 115) by androgen withdrawal. Furuya Y; Isaacs JT; Shimazaki J Jpn J Cancer Res; 1995 Dec; 86(12):1159-65. PubMed ID: 8636004 [TBL] [Abstract][Full Text] [Related]
2. Apoptosis in androgen-independent mouse mammary tumor cells induced by 5-fluorodeoxyuridine but not by androgen withdrawal. Furuya Y; Shimazaki J Anticancer Res; 1996; 16(5A):2613-8. PubMed ID: 8917359 [TBL] [Abstract][Full Text] [Related]
3. Critical role for p27Kip1 in cell cycle arrest after androgen depletion in mouse mammary carcinoma cells (SC-3). Menjo M; Kaneko Y; Ogata E; Ikeda K; Nakanishi M Oncogene; 1998 Nov; 17(20):2619-27. PubMed ID: 9840925 [TBL] [Abstract][Full Text] [Related]
4. Induction of apoptosis in androgen-independent mouse mammary cell line by 1, 25-dihydroxyvitamin D3. Furuya Y; Ohta S; Shimazaki J Int J Cancer; 1996 Sep; 68(1):143-8. PubMed ID: 8895555 [TBL] [Abstract][Full Text] [Related]
5. Growth-stimulating effect of pharmacological doses of estrogen on androgen-dependent Shionogi carcinoma 115 in vivo but not in cell culture. Noguchi S; Nishizawa Y; Nakamura N; Uchida N; Yamaguchi K; Sato B; Kitamura Y; Matsumoto K Cancer Res; 1987 Jan; 47(1):263-8. PubMed ID: 3791211 [TBL] [Abstract][Full Text] [Related]
6. Androgen ablation-induced programmed death of prostatic glandular cells does not involve recruitment into a defective cell cycle or p53 induction. Furuya Y; Lin XS; Walsh JC; Nelson WG; Isaacs JT Endocrinology; 1995 May; 136(5):1898-906. PubMed ID: 7720636 [TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis in an androgen-independent mouse cell line by transforming growth factor-beta 1. Furuya Y; Ohta S; Shimazaki J J Exp Ther Oncol; 1996 Nov; 1(6):377-84. PubMed ID: 9414428 [TBL] [Abstract][Full Text] [Related]
8. Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro. Wärri AM; Huovinen RL; Laine AM; Martikainen PM; Härkönen PL J Natl Cancer Inst; 1993 Sep; 85(17):1412-8. PubMed ID: 8350365 [TBL] [Abstract][Full Text] [Related]
9. [Molecular mechanism of androgen-dependent transformation--analysis using serum-free culture system]. Koga M; Kouhara H; Sato B Hum Cell; 1993 Sep; 6(3):176-81. PubMed ID: 8297813 [TBL] [Abstract][Full Text] [Related]
10. Effects of intermittent androgen suppression on the stem cell composition and the expression of the TRPM-2 (clusterin) gene in the Shionogi carcinoma. Akakura K; Bruchovsky N; Rennie PS; Coldman AJ; Goldenberg SL; Tenniswood M; Fox K J Steroid Biochem Mol Biol; 1996 Dec; 59(5-6):501-11. PubMed ID: 9010356 [TBL] [Abstract][Full Text] [Related]
11. Effect of tumour progression on the androgenic regulation of the androgen receptor, TRPM-2 and YPT1 genes in the Shionogi carcinoma. Rennie PS; Bruchovsky N; Akakura K; Goldenberg SL; Otal N; Akakura S; Wong P; Tenniswood M J Steroid Biochem Mol Biol; 1994 Jul; 50(1-2):31-40. PubMed ID: 8049130 [TBL] [Abstract][Full Text] [Related]
12. Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models. Miyake H; Nelson C; Rennie PS; Gleave ME Cancer Res; 2000 May; 60(9):2547-54. PubMed ID: 10811138 [TBL] [Abstract][Full Text] [Related]
13. Action mechanisms of physiological doses of androgen or pharmacological doses of estrogen in growth stimulation of Shionogi carcinoma 115 in mice. Nakamura N; Nishizawa Y; Noguchi S; Uchida N; Sato B; Matsumoto K J Steroid Biochem; 1987; 27(1-3):459-64. PubMed ID: 2961936 [TBL] [Abstract][Full Text] [Related]
14. Progression of androgen-sensitive mouse tumor (Shionogi carcinoma 115) to androgen-insensitive tumor after long-term removal of testosterone. Sato N; Watabe Y; Suzuki H; Shimazaki J Jpn J Cancer Res; 1993 Dec; 84(12):1300-8. PubMed ID: 8294220 [TBL] [Abstract][Full Text] [Related]
15. Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer. Miyake H; Nelson C; Rennie PS; Gleave ME Cancer Res; 2000 Jan; 60(1):170-6. PubMed ID: 10646870 [TBL] [Abstract][Full Text] [Related]
16. [Stimulation and inhibition of the growth of sex-steroid-dependent tumors]. Matsumoto K; Nakamura N; Sato B Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):771-9. PubMed ID: 3566289 [TBL] [Abstract][Full Text] [Related]
17. Use of antisense oligonucleotides targeting the antiapoptotic gene, clusterin/testosterone-repressed prostate message 2, to enhance androgen sensitivity and chemosensitivity in prostate cancer. Gleave ME; Miyake H; Zellweger T; Chi K; July L; Nelson C; Rennie P Urology; 2001 Aug; 58(2 Suppl 1):39-49. PubMed ID: 11502446 [TBL] [Abstract][Full Text] [Related]
18. Isolation of an androgen-inducible novel lipocalin gene, Arg1, from androgen-dependent mouse mammary Shionogi carcinoma cells. Kobayashi M; Kinouchi T; Hakamata Y; Kamiakito T; Kuriki K; Suzuki K; Tokue A; Fukayama M; Tanaka A J Steroid Biochem Mol Biol; 2001 May; 77(2-3):109-15. PubMed ID: 11377975 [TBL] [Abstract][Full Text] [Related]
19. Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Kyprianou N; English HF; Isaacs JT Cancer Res; 1990 Jun; 50(12):3748-53. PubMed ID: 2340521 [TBL] [Abstract][Full Text] [Related]
20. Roles of transforming growth factor beta in inhibition of androgen-induced growth of Shionogi carcinoma cells in serum-free medium. Yamanishi H; Nonomura N; Tanaka A; Yasui T; Nishizawa Y; Matsumoto K; Sato B Cancer Res; 1990 Oct; 50(19):6179-83. PubMed ID: 2169337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]